Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".
Starting in March, every first Friday of the month from 9:00 p.m. to midnight, Mazzoni Center’s The Real Impact Project (aka TRIP) will host "TRIP Nights" at the Washington West Project (1201 Locust Street). TRIP Nights offers a safe space for gay/bisexual men of color to come and express themselves in a freeing environment with peers along with providing testing for Read more...
In the wake of the new Presidential administration, and with a Congress that has announced its intention of restricting reproductive healthcare rights, a major area of concern has been what effect the new administration will have on the country’s healthcare. In particular, the sense that reproductive healthcare – especially access to birth control – will be under threat has been of primary concern. In the days immediately after the election, lots of people online were cautioning those in need of birth control to get an intrauterine device (IUD) – a long- Read more...

In this month's Mission Moments video, Mazzoni Youth Education Specialist Nefertari Sloan talks about making an impact on Philadelphia youth through her work with the How to Love program, which engages young people in conversation about healthy relationships, sexuality and self-esteem.

For more info. on youth programs at Mazzoni Center click here.

(music credit: "Quest to the Temple of the Sun" by D'lay is licensed under CC BY 2.0: Read more...

The Supreme Court of the United States has issued its most significant ruling on abortion in nearly 25 years.  By a vote of 5 to 3 the justices declared that a 2013 Texas law requiring abortion providers to meet a numbers of strict standards created an undue burden for women seeking to terminate their pregnancies and was therefore unconstitutional.

Read more...
Robert J Winn, MD

It’s been three years since the FDA approved PrEP (Pre-Exposure Prophylaxis) for use by HIV-negative individuals to prevent them from being infected with HIV.  When PrEP as treatment was first introduced, there was a great deal of excitement in the provider community, particularly among those of us who specialize in treating people with HIV and those at higher risk of contracting it.  In its original clinical trials PrEP showed remarkable efficacy as a prevention tool.

Earlier this fall researchers at Kaiser Permanente Medical Center in San Francisco released what I Read more...